INO vs TECH · rev $65.3K vs P/E 65, rev $1.22B
Inovio Pharmaceuticals Inc (INO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
INO currently screens at market cap $88.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the INO and TECH stock pages for the full models.
Not investment advice.